总时间（秒）：50.29
问答时间（秒）：46.77

<think>
Okay, let's start by going through the user's query and the provided context. The user wants me to extract information from the given scientific paper about genetic variants, diseases, and experimental methods, then structure it into a specific JSON format. They also mentioned using HGVS nomenclature and MONDO terms, so I need to make sure those are standardized.

First, the paper discusses LRRK2 mutations in Parkinson's disease. The variants mentioned are R1441C, R1441G, R1441H, Y1699C, I2020T, R1728H, G2019S, and T2031S. I need to check if these are in the correct HGVS format. However, the paper doesn't provide transcript numbers or cDNA changes, only protein changes. Since the user requires HGVS nomenclature via API, but the context doesn't have that info, I might have to use N.D. here. But maybe the variants are listed as protein changes, so I can note that.

Next, the disease is Parkinson's disease. The MONDO term for Parkinson's is MONDO:0005319. I'll need to confirm that from the MONDO database.

For the experimental methods, the paper mentions techniques like isolating LRRK2 from cells, phosphorylation analysis, and studying cellular localization. The methods include using Swiss 3T3 cells, mouse tissues, knock-in mice. The readouts involve phosphorylation levels, localization changes, and kinase activity. The user wants details on replicates, controls, etc. The paper doesn't explicitly mention biological or technical replicates, so those would be N.D. Similarly, controls like positive or negative might not be detailed, so again N.D. However, the paper does mention using wild-type as controls in some contexts, but I need to check the exact text.

The variants R1728H, G2019S, T2031S are associated with increased kinase activity. The others (R1441C, R1441G, R1441H, Y1699C, I2020T) cause reduced phosphorylation and altered localization. The approved assay part is tricky. Are these methods commonly used for Parkinson's? I think techniques like Western blot and immunofluorescence are standard, but the user might need a yes or no based on general knowledge.

Putting this all together, the JSON structure will have the variants with protein changes, MONDO term for Parkinson's, and experimental methods with details as per the paper. Where information is missing, I'll use N.D. and note the source where possible.
</think>

{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "N.D. (Protein change: R1441C)",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "R1441C (Reduced phosphorylation at S935, altered localization)"
        },
        {
          "HGVS": "N.D. (Protein change: R1441G)",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "R1441G (Reduced phosphorylation at S935, altered localization)"
        },
        {
          "HGVS": "N.D. (Protein change: R1441H)",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "R1441H (Reduced phosphorylation at S935, altered localization)"
        },
        {
          "HGVS": "N.D. (Protein change: Y1699C)",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "Y1699C (Reduced phosphorylation at S935, altered localization)"
        },
        {
          "HGVS": "N.D. (Protein change: I2020T)",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "I2020T (Reduced phosphorylation at S935, altered localization)"
        },
        {
          "HGVS": "N.D. (Protein change: R1728H)",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "R1728H (Increased kinase activity)"
        },
        {
          "HGVS": "N.D. (Protein change: G2019S)",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "G2019S (Increased kinase activity)"
        },
        {
          "HGVS": "N.D. (Protein change: T2031S)",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "T2031S (Increased kinase activity)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005319"
  },
  "Experiment Method": [
    {
      "Assay Method": "Phosphorylation analysis and cellular localization",
      "Material used": {
        "Material Source": "Cell line and mouse tissues",
        "Material Name": "Swiss 3T3 cells, mouse tissues, LRRK2 knock-in mice",
        "Description": "LRRK2 was isolated from Swiss 3T3 cells and mouse tissues. Knock-in mice were used to study variants."
      },
      "Readout type": "Quantitative and qualitative",
      "Readout description": [
        {
          "Variant": "N.D. (Protein change: R1441C)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation at S935, altered localization",
          "Result Description": "R1441C variant showed reduced phosphorylation at S935 and altered localization compared to wild-type."
        },
        {
          "Variant": "N.D. (Protein change: R1441G)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation at S935, altered localization",
          "Result Description": "R1441G variant showed reduced phosphorylation at S935 and altered localization."
        },
        {
          "Variant": "N.D. (Protein change: R1441H)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation at S935, altered localization",
          "Result Description": "R1441H variant showed reduced phosphorylation at S935 and altered localization."
        },
        {
          "Variant": "N.D. (Protein change: Y1699C)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation at S935, altered localization",
          "Result Description": "Y1699C variant showed reduced phosphorylation at S935 and altered localization."
        },
        {
          "Variant": "N.D. (Protein change: I2020T)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced phosphorylation at S935, altered localization",
          "Result Description": "I2020T variant showed reduced phosphorylation at S935 and altered localization."
        },
        {
          "Variant": "N.D. (Protein change: R1728H)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "R1728H variant showed increased kinase activity."
        },
        {
          "Variant": "N.D. (Protein change: G2019S)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "G2019S variant showed increased kinase activity."
        },
        {
          "Variant": "N.D. (Protein change: T2031S)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "T2031S variant showed increased kinase activity."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Approved assay": "Yes"
    }
  ]
}